Friday, September 21, 2018
   
Text Size

Sept. 18 - Senate Passes Opioid Crisis Response Act

Brunswick Business Journal Staff Report
 
September 18, 2018 - U.S. Senator Johnny Isakson applauded the Senate passage of the Opioid Crisis Response Act of 2018, a bipartisan, comprehensive legislation to improve the federal government’s response to the opioid epidemic. This week, September 16 - 22, has been recognized as Prescription Opioid and Heroin Epidemic Awareness Week.
 
The Act combines more than 70 proposals, three of which were authored by Isakson, from five Senate committees, including two that Isakson sits on: the Senate Committee on Health, Education, Labor and Pensions and the Senate Committee on Finance. The legislation takes a multi-pronged approach to attack the opioid crisis through prevention, treatment and recovery, support for caregivers and families, safety, medical research, and improved border security measures, in addition to tackling the crisis through the Medicare and Medicaid programs.
 
“The opioid crisis has touched my own family just as it has affected so many other Georgia families, veterans and businesses,” said Isakson in a press release. “President Trump declared the opioid crisis a national health emergency last year, and after months of work across many committees and both sides of the aisle, I’m proud that the Senate has passed such a comprehensive measure to fight the opioid crisis in Georgia and across the country. We must all work together to tackle this crisis.”
 
Isakson is a co-sponsor of the Senate Health, Education, Labor and Pensions Committee’s Opioid Crisis Response Act legislation, which is included in the final package. A provision of this legislation authorizes and improves the state targeted responses grants from the Isakson-backed 21st Century Cures Act to improve flexibility for states in using the grants.
 
Additionally, Isakson authored several provisions that were included in the final package addressing Medicare and Medicaid. Medicare patients are a particularly high-risk population. In 2016, one-third of Medicare patients with a prescription drug plan had a prescription for an opioid. 
 
Originally introduced as S.2900 by Isakson and a bipartisan group of senators, the Comprehensive Screenings for Seniors Act of 2018 adds potential substance use disorders and a review of any current opioid prescriptions as part of the initial “Welcome to Medicare” exam and the wellness visit under the Medicare program.
 
Isakson also introduced S.2769, another measure included in the package that requires Centers for Medicare and Medicaid Services to develop an overall action plan for Medicare and Medicaid to enhance the treatment and prevention of opioid addiction and the coverage and reimbursement of medication-assisted treatment for opioid addiction.
 
A third measure sponsored by Isakson would require the U.S. Department of Health and Human Services secretary to support states seeking to provide housing-related support and services and care coordination services under Medicaid to beneficiaries with substance use disorders and issue a report detailing an action plan to do so within 180 days after enactment.
 
The Opioid Crisis Response Act of 2018 will:
  • Reduce use and supply of opioids, including the STOP Act to help stop illegal drugs such as dangerous Chinese-produced fentanyl at the border, as well as providing flexible grants for states to better share Prescription Drug Monitoring Programs data. These programs ensure addicts do not go “doctor shopping” for multiple prescriptions at the same time.
  • Encourage recovery by supporting states and Indian tribes in addressing substance use disorders, establishing comprehensive opioid recovery centers, expanding access to medication-assisted treatment, and improving community support, access to health professionals, tele-health services and long-distance care, and recovery housing services.
  • Support caregivers and families by improving plans for safe care and support for substance-exposed babies and their mothers, promoting family-focused treatment and recovery, aiding youth with substance use disorders, and strengthening trauma-informed care and support in schools and early childhood education programs.
  • Drive innovation and long-term solutions by advancing cutting-edge research to spur discovery and development of new non-addictive painkillers and speeding up approval pathways for these alternative treatment options to get them into the hands of patients sooner. It would also address the economic and workforce impacts of the opioid crisis, ensure parity in mental health and substance use disorder benefits, and improve pain management.
  •  

Page 1 of 64

CLICK to get NEWS ALERTS!

Follow Us!

  • Facebook: BrunswickDailyNews
  • Google+: brunswickbusinessjournal
  • Twitter: https://twitter.com/BrunsDailyNews

SavDaily

BBJ Top Jobs
MY ACCOUNT
CONTACT
SOCIAL
MORE
ADVERTISE
Coastal Empire News
Headquarters: 35 Barnard St., Suite 300, Savannah, GA. 31401.
Tel: 912-388-4692 | Hours: 8:30 a.m. to 5:00 p.m.

Copyright 2018 - Coastal Empire News | Designed by Absolute Marketing